{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T03:38:54Z","timestamp":1790912334658,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100005297","name":"Medical University of Bialystok","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005297","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Leading National Research Center in Bialystok"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.cyto.2016.02.005","type":"journal-article","created":{"date-parts":[[2016,2,22]],"date-time":"2016-02-22T17:15:20Z","timestamp":1456161320000},"page":"7-12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Alterations of soluble TWEAK and CD163 concentrations in patients with chronic heart failure"],"prefix":"10.1016","volume":"80","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6457-704X","authenticated-orcid":false,"given":"Katarzyna","family":"Ptaszynska-Kopczynska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Marcinkiewicz-Siemion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Lisowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Waszkiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcin","family":"Witkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malgorzata","family":"Jasiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Miklasz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Jakim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bogdan","family":"Galar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wlodzimierz Jerzy","family":"Musial","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9465-2581","authenticated-orcid":false,"given":"Karol Adam","family":"Kaminski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"20","key":"10.1016\/j.cyto.2016.02.005_b0005","article-title":"Congestive heart failure: fifty years of progress","volume":"102","author":"Braunwald","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.cyto.2016.02.005_b0010","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s11897-008-0012-2","article-title":"Immune modulation: role of the inflammatory cytokine cascade in the failing human heart","volume":"5","author":"Satoh","year":"2008","journal-title":"Curr. Heart Fail. Rep."},{"key":"10.1016\/j.cyto.2016.02.005_b0015","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S1071-9164(96)80047-9","article-title":"Basic mechanisms in heart failure: the cytokine hypothesis","volume":"2","author":"Seta","year":"1996","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.cyto.2016.02.005_b0020","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1161\/01.CIR.92.6.1479","article-title":"Tumour necrosis factor soluble receptors in patients with various degrees of congestive heart failure","volume":"92","author":"Ferrari","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.cyto.2016.02.005_b0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cyto.2007.09.007","article-title":"TWEAKing tissue remodeling by a multifunctional cytokine: role of TWEAK\/Fn14 pathway in health and disease","volume":"40","author":"Burkly","year":"2007","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2016.02.005_b0030","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1093\/cvr\/cvp360","article-title":"TWEAK is a positive regulator of cardiomyocyte proliferation","volume":"85","author":"Novoyatleva","year":"2010","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.cyto.2016.02.005_b0035","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1161\/CIRCULATIONAHA.108.837286","article-title":"A novel role for tumor necrosis factor-like weak inducer of apoptosis (TWEAK) in the development of cardiac dysfunction and failure","volume":"119","author":"Jain","year":"2009","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.cyto.2016.02.005_b0040","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.atherosclerosis.2010.02.016","article-title":"Soluble TWEAK is markedly upregulated in patients with ST-elevation myocardial infarction and related to an adverse short-term outcome","volume":"211","author":"Chorianopoulos","year":"2010","journal-title":"Atherosclerosis"},{"issue":"11","key":"10.1016\/j.cyto.2016.02.005_b0045","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1093\/eurjhf\/hfp139","article-title":"Decreased soluble TWEAK levels predict an adverse prognosis in patients with chronic stable heart failure","volume":"11","author":"Chorianopoulos","year":"2009","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.cyto.2016.02.005_b0050","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.atherosclerosis.2010.08.061","article-title":"Differences in the predictive value of tumor necrosis factor-like weak inducer of apoptosis (TWEAK) in advanced ischemic and non-ischemic heart failure","volume":"213","author":"Richtera","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cyto.2016.02.005_b0055","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1016\/j.molimm.2010.02.008","article-title":"Scavenger receptor CD163, a Jack-of-all-trades and potential target for cell-directed therapy","volume":"47","author":"Van Gorp","year":"2010","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.cyto.2016.02.005_b0060","doi-asserted-by":"crossref","first-page":"8183","DOI":"10.4049\/jimmunol.178.12.8183","article-title":"A previously unrecognized protein-protein interaction between TWEAK and CD163: potential biological implications","volume":"178","author":"Bover","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2016.02.005_b0065","doi-asserted-by":"crossref","first-page":"980327","DOI":"10.1155\/2013\/980327","article-title":"Haptoglobin genotype-dependent anti-inflammatory signaling in CD163(+) macrophages","volume":"2013","author":"Landis","year":"2013","journal-title":"Int. J. Inflam."},{"key":"10.1016\/j.cyto.2016.02.005_b0070","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1006\/cyto.2000.0720","article-title":"Human monocytes express CD163, which is upregulated by IL-10 and identical to p155","volume":"12","author":"Sulahian","year":"2000","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2016.02.005_b0075","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1046\/j.1365-2141.2002.03790.x","article-title":"Induction of the CD163-dependent haemoglobin uptake by macrophages as a novel anti-inflammatory action of glucocorticoids","volume":"119","author":"Schaer","year":"2002","journal-title":"Br. J. Haematol."},{"issue":"1","key":"10.1016\/j.cyto.2016.02.005_b0080","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/jlb.67.1.97","article-title":"Regulation of scavenger receptor CD163 expression in human monocytes and macrophages by pro- and antiinflammatory stimuli","volume":"67","author":"Buechler","year":"2000","journal-title":"J. Leukoc. Biol."},{"issue":"6","key":"10.1016\/j.cyto.2016.02.005_b0085","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/sji.12222","article-title":"Soluble CD163, a specific macrophage activation marker, is decreased by anti-TNF-\u03b1 antibody treatment in active inflammatory bowel disease","volume":"80","author":"Dige","year":"2014","journal-title":"Scand. J. Immunol."},{"issue":"2","key":"10.1016\/j.cyto.2016.02.005_b0090","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/imm.12167","article-title":"Interleukin-1\u03b2 triggers the differentiation of macrophages with enhanced capacity to present mycobacterial antigen to T cells","volume":"141","author":"Schenk","year":"2014","journal-title":"Immunology"},{"key":"10.1016\/j.cyto.2016.02.005_b0095","doi-asserted-by":"crossref","first-page":"780502","DOI":"10.1155\/2013\/780502","article-title":"Evolution of the macrophage CD163 phenotype and cytokine profiles in a human model of resolving inflammation","volume":"2013","author":"Evans","year":"2013","journal-title":"Int. J. Inflam."},{"key":"10.1016\/j.cyto.2016.02.005_b0100","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.atherosclerosis.2005.05.004","article-title":"The monocytic lineage specific soluble CD163 is a plasma marker of coronary atherosclerosis","volume":"184","author":"Aristoteli","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cyto.2016.02.005_b0105","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.atherosclerosis.2011.09.016","article-title":"Impact of soluble TWEAK and CD163\/TWEAK ratio on long-term cardiovascular mortality in patients with peripheral arterial disease","volume":"219","author":"Urbonavicienea","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cyto.2016.02.005_b0110","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1161\/01.ATV.0000258972.10109.ff","article-title":"Identification of soluble tumor necrosis factor-like weak inducer of apoptosis (sTWEAK) as a possible biomarker of subclinical atherosclerosis","volume":"27","author":"Blanco-Colio","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.cyto.2016.02.005_b0115","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.atherosclerosis.2007.10.022","article-title":"Serum levels of the atherosclerosis biomarker sTWEAK are decreased in type 2 diabetes and end-stage renal disease","volume":"199","author":"Kralisch","year":"2008","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.cyto.2016.02.005_b0120","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.cyto.2010.01.007","article-title":"Circadian variations of interleukin 6 in coronary circulations of patients with myocardial infarction","volume":"50","author":"Bonda","year":"2010","journal-title":"Cytokine"},{"issue":"1","key":"10.1016\/j.cyto.2016.02.005_b0125","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/eci.12375","article-title":"Reduced circulating levels of TWEAK are associated with gestational diabetes mellitus","volume":"45","author":"Sim\u00f3n-Muela","year":"2015","journal-title":"Eur. J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.cyto.2016.02.005_b0130","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.cyto.2013.12.013","article-title":"Serum levels of CD163 and TWEAK in patients with pulmonary arterial hypertension","volume":"66","author":"Jasiewicz","year":"2014","journal-title":"Cytokine"},{"issue":"5\u20136","key":"10.1016\/j.cyto.2016.02.005_b0135","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.cyto.2006.06.004","article-title":"Changes in the pro-inflammatory cytokine production and peritoneal macrophage function in rats with chronic heart failure","volume":"34","author":"Batista","year":"2006","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2016.02.005_b0140","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1182\/blood.V99.1.378","article-title":"Identification of the hemoglobin scavenger receptor\/CD163 as a natural soluble protein in plasma","volume":"99","author":"M\u00f8ller","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.cyto.2016.02.005_b0145","doi-asserted-by":"crossref","first-page":"365","DOI":"10.5603\/FHC.2011.0052","article-title":"CD163 and its role in inflammation","volume":"9","author":"Kowal","year":"2011","journal-title":"Folia Histochem. Cytobiol."},{"issue":"6","key":"10.1016\/j.cyto.2016.02.005_b0150","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.5301\/jn.5000245","article-title":"Soluble TWEAK is associated with atherosclerotic burden in patients with chronic kidney disease","volume":"26","author":"Valdivielso","year":"2013","journal-title":"J. Nephrol."}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466616300291?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466616300291?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,4]],"date-time":"2019-09-04T17:47:35Z","timestamp":1567619255000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466616300291"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":30,"alternative-id":["S1043466616300291"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2016.02.005","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alterations of soluble TWEAK and CD163 concentrations in patients with chronic heart failure","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2016.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}